Gatuline (Oak Apple Gall Extract)
Gatuline is a standardized extract derived from oak apple galls (Quercus infectoria), rich in gallic acid, ellagic acid, and hydrolyzable tannins. These polyphenols exert antioxidant and potential matrix-supporting effects by scavenging free radicals and modulating collagen-degrading enzyme activity.
Origin & History
Gatuline Age Defense NP is a branded aqueous extract derived from walnut (Juglans regia) seedcake, a byproduct of walnut oil production from the Rhône-Alpes region of France. The extract is produced through water-based extraction, yielding a clear to slightly cloudy yellow liquid rich in polyphenols (0.10-0.80 g/L), phytic acid (1.0-3.0 g/L), amino acids, and minerals.
Historical & Cultural Context
Gatuline is a modern upcycled cosmetic ingredient from walnut oil production waste with no documented traditional medicinal uses. While oak galls (a different ingredient) have historical use in Unani and Ayurvedic medicine, this walnut seedcake extract has no established traditional applications.
Health Benefits
• Antioxidant protection against oxidative stress through polyphenol content including gallic acid derivatives and ellagic acid (preliminary evidence from in vitro studies) • Potential skin and hair protection from UV/pollution-induced damage (manufacturer claims only, no clinical trials) • May support cellular metabolism and preserve antioxidant pools (mechanism proposed but not clinically validated) • Possible anti-aging effects for skin through environmental protection (topical use only, no human studies) • Note: No human clinical trials exist for this ingredient; all benefits are based on theoretical mechanisms
How It Works
The gallic acid and ellagic acid in Gatuline donate hydrogen atoms to neutralize reactive oxygen species, interrupting lipid peroxidation chain reactions at the cellular membrane level. Hydrolyzable tannins in the extract may inhibit matrix metalloproteinases (MMP-1 and MMP-3), enzymes responsible for degrading collagen and elastin in the dermis, thereby theoretically preserving extracellular matrix integrity. Ellagic acid has also demonstrated inhibition of tyrosinase activity in vitro, suggesting a secondary pathway relevant to skin tone and oxidative pigmentation.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses were identified for Gatuline walnut seed extract. Evidence is limited to manufacturer claims and proposed mechanisms based on the extract's polyphenol content. Related oak gall studies exist but are not applicable to this specific branded ingredient.
Clinical Summary
Available evidence for Gatuline is largely limited to in vitro cell culture studies and manufacturer-sponsored cosmetic efficacy data, with no independent peer-reviewed randomized controlled trials published as of 2024. In vitro studies demonstrate concentration-dependent free radical scavenging (DPPH assay IC50 values reported for gallic acid derivatives), but these do not translate directly to topical or oral bioavailability in humans. Manufacturer claims reference small pilot cosmetic studies measuring skin elasticity via cutometry, though sample sizes, methodology, and raw data are not publicly available for independent evaluation. The broader polyphenol literature on gallic acid and ellagic acid provides biological plausibility, but direct clinical evidence specific to Gatuline as a formulated ingredient remains insufficient to support strong efficacy claims.
Nutritional Profile
Gatuline (Oak Apple Gall Extract) is a concentrated botanical extract, not a conventional nutritional ingredient, and thus does not contribute meaningful macronutrients (proteins, fats, or carbohydrates) at typical usage concentrations (0.1–2% in formulations). Its nutritional relevance lies entirely in its bioactive polyphenol content. Primary bioactive compounds include: gallic acid (typically 50–70% of total polyphenol fraction in oak gall extracts), ellagic acid (reported at 5–15% of polyphenol content), tannins — predominantly gallotannins and ellagitannins (total tannin content of raw oak galls ranges 50–70% dry weight, though commercial extracts are standardized to varying degrees), and minor flavonoids including quercetin derivatives. Gatunic acid has been identified as a characteristic marker compound in some commercial preparations. No significant vitamin or mineral content is contributed at functional dosages. Fiber content is negligible in extract form. Bioavailability of gallic acid is relatively moderate in humans (estimated oral absorption ~50–60% based on related polyphenol studies), though ellagitannins require gut microbiome conversion to urolithins for systemic activity, making bioavailability highly individual-dependent. In topical or specialized oral delivery formats (as used in some Gatuline-branded products), systemic bioavailability data specific to this extract is not publicly established in peer-reviewed literature.
Preparation & Dosage
Manufacturer-recommended use level is 0.5-6% in topical cosmetic formulations only. No clinically studied dosages exist for oral supplement forms. No standardization details beyond cosmetic specifications (polyphenols 0.10-0.80 g/L gallic acid equivalent, phytic acid 1.0-3.0 g/L) are available. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin C, Vitamin E, Green Tea Extract, Resveratrol, Coenzyme Q10
Safety & Interactions
Gatuline is generally regarded as well-tolerated in cosmetic concentrations, with no widely reported systemic adverse effects at typical topical use levels. High oral doses of tannin-rich extracts in general can cause gastrointestinal irritation, nausea, and may reduce iron absorption by chelating non-heme iron, making co-administration with iron supplements or in iron-deficient individuals a potential concern. Ellagic acid has shown CYP3A4 inhibitory activity in vitro, raising a theoretical interaction risk with drugs metabolized by this enzyme (e.g., statins, certain immunosuppressants), though clinical significance at cosmetic exposure levels is unestablished. Safety in pregnancy, lactation, and pediatric populations has not been formally studied, so use in these groups should follow precautionary principles.